Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation
In XANTUS study the safety and efficacy of factor Xa inhibitor rivaroxaban were evaluated in routine clinical practice in patients with non-valvular atrial fibrillation. In consecutive patients who started treatment with rivaroxaban, all adverse events were recorded every 3 months for 1 year. Conclu...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Boek |
| Gepubliceerd in: |
Столичная издательская компания,
2016-09-01T00:00:00Z.
|
| Onderwerpen: | |
| Online toegang: | Connect to this object online. |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Internet
Connect to this object online.3rd Floor Main Library
| Plaatsingsnummer: |
A1234.567 |
|---|---|
| Kopie 1 | Beschikbaar |